Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$24.99 USD
+0.19 (0.77%)
Updated May 15, 2024 04:00 PM ET
After-Market: $24.96 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.44 | 0.00% |
Earnings Summary
For their last quarter, Mirum Pharmaceuticals (MIRM) reported earnings of -$0.54 per share, missing the Zacks Consensus Estimate of -$0.40 per share. This reflects a negative earnings surprise of 35.00%. Look out for MIRM's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year increase of 52.17%.
Earnings History
Price & Consensus
Zacks News for MIRM
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
MIRM: What are Zacks experts saying now?
Zacks Private Portfolio Services